Elelyso (taliglucerase alfa)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
ADVERSE REACTIONS
Immunogenicity
(updated paragraph) In a clinical trial of treatment-naïve pediatric patients, 2...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts